Toshiba America Medical Systems has received clearance from the U.S. Food and Drug Administration (FDA) for its newest dose reduction technology, adaptive iterative dose reduction (AIDR) 3D.
AIDR 3D is Toshiba's third-generation iterative dose reconstruction software. It can be integrated with the company's SureExposure 3D software, which calculates the minimum radiation exposure required for every exam and adjusts the dose for each patient based on a preset, targeted level of image quality, according to the firm.
The company plans to offer AIDR 3D software upgrades and related training at no cost to all existing Aquilion One, Aquilion Premium, and Aquilion Prime CT customers.
